Veterinary CRO Market Outlook 2035: Global Industry Set to Cross US$ 1.6 Billion With 7.1% CAGR

The veterinary contract research organization (CRO) market is witnessing steady, long-term expansion as the animal health industry evolves toward more advanced therapeutics, biologics, and diagnostics. Valued at US$ 770.8 million in 2024, the global veterinary CRO market is expected to grow at a healthy CAGR of 7.1% between 2025 and 2035, ultimately surpassing US$ 1.6 billion by 2035. Rising R&D investments in companion animal and livestock health, increasing zoonotic disease prevalence, and rapid innovation in veterinary pharmaceuticals are key factors propelling market demand.

Dive Deeper into Data: Get Your In-Depth Sample Now!

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86567

Growing Emphasis on Animal Health Research Accelerates CRO Demand

Growing emphasis on animal health research is significantly accelerating demand for veterinary CRO services. As spending on livestock productivity, food safety, and companion animal care increases across global markets, pharmaceutical companies are expanding pipelines for vaccines, anti-infectives, parasiticides, pain management drugs, and advanced biologics. This rise in R&D complexity is driving greater reliance on CROs offering preclinical research, clinical trial oversight, pathology, toxicology, regulatory support, and laboratory testing. With companies focusing on core innovation and seeking faster, more compliant development cycles, outsourcing has become a cost-efficient strategy. As a result, CROs are playing a crucial role in improving trial efficiency, ensuring regulatory readiness, and supporting global market expansion.

Expanding Companion Animal Market Strengthens Research Opportunities

The sharp rise in pet ownership globally-especially dogs and cats-continues to reshape the veterinary therapeutics landscape. Higher diagnosis rates, improved access to advanced veterinary clinics, and increasing demand for specialty medications are prompting pharmaceutical firms to pursue complex drug development programs.

This shift from traditional medicines to biologics, monoclonal antibodies, oncology drugs, and chronic disease therapeutics has significantly increased the need for CROs with specialized expertise. Companion animal clinical trials, once limited in scope, now represent a meaningful share of outsourced veterinary research.

Regulatory Evolution Enhances CRO Involvement

Animal health regulatory frameworks in the U.S., Europe, and Asia-Pacific have become more aligned with human drug development standards, prioritizing safety, efficacy, and trial transparency. This evolution increases the technical complexity of veterinary drug approvals, making CRO involvement essential.

Regulatory bodies such as:

FDA's Center for Veterinary Medicine (CVM)

European Medicines Agency (EMA)

World Organisation for Animal Health (WOAH)

now require robust evidence supporting veterinary product claims. CROs play a central role in generating, validating, and managing this data, further strengthening their importance in the global R&D ecosystem.

Regional Landscape

North America

The region holds the dominant share due to strong pharmaceutical R&D infrastructure, large pet populations, and high expenditure on veterinary healthcare. The U.S. leads the industry with extensive clinical trial networks, academic research partnerships, and strong regulatory compliance systems. Several of the world's largest animal health companies operate here, significantly driving CRO demand.

Europe

Europe remains a mature market with strong veterinary research culture and advanced livestock management practices. Countries such as Germany, France, the U.K., and the Netherlands have well-established CRO networks specializing in toxicology, pathology, and advanced biologics trials.

Asia-Pacific

APAC is the fastest-growing region. Rapid growth in livestock production, rising prevalence of zoonotic diseases, and increasing investment from global pharmaceutical companies are accelerating CRO market penetration. China, India, and Australia are emerging as strategic hubs for cost-efficient and large-scale veterinary studies.

Latin America & Middle East

Emerging markets present growing opportunity due to expansions in cattle, poultry, and aquaculture industries. As disease surveillance improves and veterinary medicine becomes more regulated, CROs are gaining fresh avenues for preclinical and field trial services.

Buy Now: https://www.transparencymarketresearch.com/checkout.php?rep_id=86567<ype=S

Competitive Landscape

The veterinary CRO market remains moderately consolidated, with a mix of global leaders and specialized regional firms. Companies are investing in broader service portfolios, GLP-compliant facilities, biomarker development, digital trial management platforms, and partnerships with pharmaceutical innovators.

Key players include:

Charles River Laboratories
IDEXX Laboratories, Inc.
BioAgile Therapeutics Private Limited
Royal GD
KLIFOVET GmbH
Argenta Holdco Limited
Cebiphar
Clinvet
STATKING Clinical Services
OCRvet
LÖHLEIN & WOLF VET RESEARCH
VETSPIN SRL
Inotiv
Knoell
Cloudbyz

These organizations are expanding capabilities in pathology, toxicology, large animal trials, and biologics research to keep pace with evolving veterinary drug pipelines.

Market Drivers and Emerging Opportunities

The veterinary CRO market is being propelled by several strong, interconnected forces. One of the major drivers is the rising global burden of zoonotic diseases, which has intensified the need for rapid vaccine development, large-scale field studies, and continuous monitoring across both livestock and companion animals. At the same time, the companion animal therapeutics segment is expanding rapidly, driven by growing pet ownership and increased demand for advanced medications targeting chronic, infectious, and age-related conditions. These shifts are pushing animal health companies to accelerate research, thereby strengthening reliance on outsourcing partners with specialized technical capabilities.

Livestock productivity initiatives across emerging and developed markets are also contributing to this momentum. Governments and agricultural industries are more focused than ever on improving animal welfare, ensuring food safety, and controlling economically significant diseases. This has resulted in higher investment in veterinary pharmaceuticals, diagnostics, and biologics, creating a sustained need for CRO-led studies that validate safety and efficacy.

The evolving regulatory landscape is another critical driver. As global regulatory bodies adopt stricter standards for veterinary medicines-closely mirroring human healthcare requirements-animal health companies must generate more rigorous, transparent, and compliant research data. This trend is increasing the complexity of drug development and elevating the role of CROs in managing comprehensive study portfolios.

Future Outlook

By 2035, the veterinary CRO market will play an even more essential role in shaping the trajectory of global animal health innovation. As pharmaceutical companies focus on faster pipeline acceleration, reduced development costs, and regulatory readiness, CRO partnerships will become indispensable. With the industry's value expected to surpass US$ 1.6 billion by 2035, the market is set for sustained growth, underpinned by strong research demand across companion animals, livestock, and emerging zoonotic disease programs.

Explore Latest Research Reports by Transparency Market Research:

Vegan Chocolate Market: https://www.transparencymarketresearch.com/vegan-chocolate-market.html

Polyhydroxyalkanoate Market: https://www.transparencymarketresearch.com/polyhydroxyalkanoate-market.html

Flooring Market : https://www.transparencymarketresearch.com/flooring-market.html

Produced Water Treatment Market: https://www.transparencymarketresearch.com/produced-water-treatment-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.